rEVO Biologics' Unattributed VC - III Round

rEVO Biologics raised a round of funding on August 22, 2005.

rEVO Biologics, fka GTC Biotherapeutics, is a rare disease company focused on developing and delivering therapeutics that are more cost effective to produce than traditional recombinant therapies. Thr…

Articles about rEVO Biologics' Unattributed VC - III Round: